Hopital Calmette; Pneumologie
Lille 59037
0 studies enrolling now · 3 studies all time
What they study most
Asthma, Idiopathic Pulmonary Fibrosis, Non-Squamous Non-Small Cell Lung Cancer
Studies at this site
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
- A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
- A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed